In light of this information, NCL offers this advice to consumers when considering GLP-1 treatment options: Before seeking treatment with a GLP-1 drug, talk to your doctor or health provider to determine if you are a candidate for treatment based on your risk factors and degree of obesity
Patients with uncontrolled diabetes, active cancer, or significant cardiovascular disease typically require careful assessment before peptide initiation
Patients with certain FTO rs9939609 genotypes may benefit from slightly higher protein intake to maintain satiety, while others thrive on structured meal timing that syncs with their medication's peak effect
Different macronutrients stimulate GLP-1 secretion to varying degrees: Fiber and complex carbohydrates : Dietary fiber, particularly soluble fiber, enhances GLP-1 secretion by slowing nutrient absorption and allowing more prolonged contact with L-cells in the distal intestine
The samples were analyzed by LC-MS/MS